e-learning
resources
Munich 2014
Tuesday, 09.09.2014
Predictors
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Biomarkers in COPD exacerbation, the role of adiponectin
V. Vitsas, M. Kardara, A. Koutsoukou, P. Michalopoulou, S. Orfanos, G. Tsoukalas, A. Kotanidou (Athens, Greece)
Source:
International Congress 2014 – Predictors
Session:
Predictors
Session type:
Thematic Poster Session
Number:
3615
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
V. Vitsas, M. Kardara, A. Koutsoukou, P. Michalopoulou, S. Orfanos, G. Tsoukalas, A. Kotanidou (Athens, Greece). Biomarkers in COPD exacerbation, the role of adiponectin. Eur Respir J 2014; 44: Suppl. 58, 3615
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Role of inflammatory biomarkers in COPD
Source: International Congress 2016 – Systemic biomarkers
Year: 2016
Features of systemic inflammation in patients with stable COPD
Source: International Congress 2014 – COPD: points to ponder
Year: 2014
Prevalence of exacerbation in COPD patients with chronic bronchitis and association with elevated serum inflammatory biomarkers
Source: International Congress 2014 – Systemic biomarkers for airway diseases
Year: 2014
Inflammatory markers and COPD phenotypes as predictors of COPD exacerbations
Source: Annual Congress 2013 –Investigating COPD in longitudinal studies
Year: 2013
Neutrophil CD 64 expression as a diagnostic marker of pneumonia in patients with acute COPD exacerbation
Source: International Congress 2014 – Markers
Year: 2014
Can red blood cell morphology be an indicator for COPD exacerbations?
Source: International Congress 2014 – Markers
Year: 2014
Mukoregulatory drugs in treating COPD
Source: International Congress 2014 – Predictors
Year: 2014
The role of COPD in development of osteoporosis
Source: International Congress 2014 – Markers
Year: 2014
Role of activated complement in COPD exacerbation recovery
Source: International Congress 2014 – Comorbidities
Year: 2014
BNP level in patients with COPD exacerbations
Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations
Year: 2013
Impact of frequent exacerbations in patients with COPD
Source: International Congress 2014 – Clinical presentations
Year: 2014
Cells biomarkers of bronchial brush-biopsies at COPD exacerbation
Source: Annual Congress 2013 –Research questions on how viruses affect the respiratory system
Year: 2013
Circulating copeptin is associated with mortality irrespectively of exacerbation rate in stable COPD
Source: International Congress 2014 – COPD - from biomarkers to novel therapeutic opportunities
Year: 2014
Blood eosinophil guided prednisolone therapy for exacerbations of COPD: A further analysis
Source: International Congress 2014 – COPD exacerbations
Year: 2014
What is the best biomarker of COPD stability?
Source: International Congress 2015 – COPD: chronic disease and comorbidities
Year: 2015
Endothelial dysfunction and systemic inflammation in different COPD phenotypes
Source: International Congress 2014 – COPD physiopathology
Year: 2014
Assessment of malondialdehyde in the airways during treatment of COPD exacerbations
Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases
Year: 2013
Exacerbations in patients with chronic obstructive lung disease (COPD) and concomitant asthma
Source: International Congress 2014 – Asthma or COPD: comorbid condition or a poorly understood single disease?
Year: 2014
Monitoring catalase activity in COPD exacerbations
Source: International Congress 2016 – Airway biomarkers
Year: 2016
Blood eosinophils and outcomes in COPD
Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept